8min chapter

Oncotarget cover image

HER2-Low Breast Cancer: A New Understanding

Oncotarget

CHAPTER

Evolving Perspectives on HER2-Low Breast Cancer Treatment

This chapter explores the complexities of HER2-low breast cancer, a newly recognized category that bridges the gap between HER2-positive and HER2-negative classifications. It emphasizes the impact of emerging treatments, particularly antibody drug conjugates, and highlights ongoing research aimed at improving diagnostics and therapy access for patients with this subtype.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode